GENTIAN Buy Hold or Sell Recommendation

<div class='circular--portrait' style='background:#000000;color: #f2f2f2;font-size:4em;padding-top: 25px;;'>GD</div>
GENT-ME -- Norway Stock  

NOK 57.00  2.50  4.59%

Assuming the 30-days trading horizon, and your above-average risk tolerance our recommendation regarding GENTIAN DIAGNOSTIC is 'Strong Hold'. Macroaxis provides GENTIAN DIAGNOSTIC buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GENT-ME positions. The advice algorithm takes into account all of GENTIAN DIAGNOSTIC available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from GENT-ME buy-and-hold perspective. Please check GENTIAN DIAGNOSTIC Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments please use Instant Ratings tool.

Search Advice


Time Horizon

Risk Tolerance

Execute Advice
Strong Hold


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon GENTIAN DIAGNOSTIC has a risk adjusted performance of 0.2936, jensen alpha of 0.5101, total risk alpha of 0.2559, sortino ratio of 0.1334 and treynor ratio of 37.93
Our buy, hold, or sell recommendation module provides unbiased buy or sell recommendations that can be used to complement current average analyst sentiment on GENTIAN DIAGNOSTIC. Our buy, hold, or sell recommendation engine provides an advice for the firm potential to grow from the perspective of an investor's risk tolerance and investing horizon. To make sure GENTIAN DIAGNOSTIC is not overpriced, please check out all GENTIAN DIAGNOSTIC fundamentals, including its shares owned by insiders, price to book, revenue, as well as the relationship between the shares owned by institutions and price to sales .

GENTIAN DIAGNOSTIC Trading Alerts and Improvement Suggestions

GENTIAN DIAGNOSTIC has very high historical volatility over the last 30 days
The company reported the revenue of 62.45 M. Net Loss for the year was (38.12 M) with profit before overhead, payroll, taxes, and interest of 29.93 M.
GENTIAN DIAGNOSTIC has accumulated about 161.07 M in cash with (25.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.46.
Roughly 49.0% of the company shares are held by company insiders

GENTIAN DIAGNOSTIC current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. GENTIAN analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. GENTIAN analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Median Price175.00
Target Mean Price175.00
Target High Price175.00
Number Of Analyst Opinions1
Target Low Price175.00
The consensus estimates and target price estimation is comprised of individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

GENTIAN DIAGNOSTIC Returns Distribution Density

The chart of the probability distribution of GENTIAN DIAGNOSTIC stock daily returns describes the distribution of returns around its average expected value. We use GENTIAN DIAGNOSTIC' stock's Value At Risk and its Upside Potential as a relative measure of the distribution. The distribution of GENTIAN DIAGNOSTIC returns is essential to provide solid investment advice for GENTIAN DIAGNOSTIC stock.
Mean Return0.52Value At Risk-3.85
Potential Upside5.97Standard Deviation3.26
 Return Density 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of GENTIAN DIAGNOSTIC historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.


Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to GENTIAN DIAGNOSTIC or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that GENTIAN DIAGNOSTIC stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a GENTIAN stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW=0.0135
Overall volatility
Information ratio =0.11


GENTIAN DIAGNOSTIC currently demonstrates below-verage downside deviation of 2.77. It has Information Ratio of 0.11 and Jensen Alpha of 0.51. However, we do advice investors to further question GENTIAN DIAGNOSTIC expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk.
 Better Than Average     
 Worse Than Average Compare GENTIAN DIAGNOSTIC to competition


FundamentalsGENTIAN DIAGNOSTICPeer Average
Return On Equity(17.22) %(0.31) %
Return On Asset(6.91) %(0.14) %
Profit Margin(61.03) %(1.27) %
Operating Margin(42.13) %(5.51) %
Current Valuation635.88 M16.62 B
Shares Outstanding15.4 M571.82 M
Shares Owned by Insiders48.77 %10.09 %
Shares Owned by Institutions26.52 %39.21 %
Price to Book3.90 X9.51 X
Price to Sales12.70 X11.42 X
Revenue62.45 M9.43 B
Gross Profit29.93 M27.38 B
EBITDA(25.04 M)3.9 B
Net Income(38.12 M)570.98 M
Cash and Equivalents161.07 M2.7 B
Cash per Share10.46 X5.01 X
Total Debt3.71 M5.32 B
Debt to Equity0.018 %48.70 %
Current Ratio16.08 X2.16 X
Book Value Per Share13.22 X1.93 K
Cash Flow from Operations(25.01 M)971.22 M
Earnings Per Share(2.48) X3.12 X
Number of Employees4618.84 K
Market Capitalization793.24 M19.03 B

About GENTIAN DIAGNOSTIC Buy or Sell Advice

When is the right time to buy or sell GENTIAN DIAGNOSTIC? Buying stocks such as GENTIAN DIAGNOSTIC isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily bases. Although GENTIAN DIAGNOSTIC investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply. Please read more on our stock advisor page.

Did You Try This Idea?

Run Trump Equities Thematic Idea Now

Trump Equities
Trump Equities Theme
Stocks that have significantly increased in valuation since Trump was elected president of the United States. Trump Equities theme has 40 constituents.
View All  Next Launch Trump Equities
Please check GENTIAN DIAGNOSTIC Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments please use Instant Ratings tool. Please also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page